Physician profile
Daniel Garvey
NPI 1467400390
$1,836.36
in general payments reported to CMS, 2019-2025
9 companies · $297 in 2025
The $297 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94.05 · 2023: $32.43 · 2024: $1,413 · 2025: $297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $976 · Food and Beverage: $766.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $975.92 |
| Food and Beverage | $766.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $975.92 | 2024 | Aquabeam System |
| Olympus America INC. | $366.83 | 2019-2025 | Itind System |
| Coloplast Corp | $189.72 | 2023-2025 | Speedicath |
| Cook Medical LLC | $183.15 | 2024 | Resonance |
| C. R. Bard, INC. & Subsidiaries | $33.46 | 2019 | |
| Merck Sharp & Dohme LLC | $29.53 | 2025 | Keytruda, Keytruda Qlex |
| 180 Medical, INC. | $20.03 | 2024 | |
| Boston Scientific Corporation | $19.82 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Garvey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.